Cheng Li

Cheng 'Cynthia' Li, PhD, currently serves as Vice President of Business Development at CytomX Therapeutics since April 2024. Prior to this role, Li was a member at Chief from June 2023 to May 2024, and Vice President of Business & Corporate Development at Spotlight Therapeutics from June 2021 to April 2024. Previous positions include Senior Director of Business Development, Director of Business Development, Market Planning Director in BD & Pipeline, and Associate Market Planning Director for Cabometyx RCC at Exelixis from April 2016 to June 2021. Early career highlights include serving as Senior Manager for Business Analysis and Insights at Amgen, a Consultant at PharmaACE, and an Adviser/Project Manager at The BALSA Group. Li earned a PhD in Molecular Cell Biology from Washington University in St. Louis from 2007 to 2014 and holds a Bachelor of Science in Biotechnology from Huazhong University of Science and Technology, completed in 2007.